| P/E (FY) | 165.0 | Sales (TTM) | $90.4M |
| Earnings (TTM) | $561,000 | ROE | 3.00% |
| Net Margin | 3.17% | ROIC | 0.98% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 215.30% |
| Market Cap | $398.7M | Trading Days | 2465 |
| 52W High | 13.74 |
| 52W Low | 8.12 |
| % Off High | −15.94% |
| YTD | 14.36% | 1Y | 1.23% |
| 3Y | 169.86% | 5Y | 17.02% |
| 10Y | 194.64% | Since incept. (ann.) | 11.67% |
US 92% · Non Us 8%
| Ann. Volatility (1Y) | 47.97% | Ann. Volatility (3Y) | 79.00% |
| Sharpe (1Y) | 0.26 | Sharpe (3Y) | 0.75 |
| Max Drawdown (1Y) | −33.74% | Max Drawdown (3Y) | −60.87% |
| Beta (3Y, vs SPY) | 1.20 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| PMI | Picard Medical, Inc. | $405.8M | — |
| MOBI | Mobia Medical, Inc. | $370.1M | — |
| CLPT | ClearPoint Neuro, Inc. | $435.7M | — |
| CARL | CARLSMED, INC. | $334.6M | — |
| OFIX | Orthofix Medical Inc. | $495.6M | — |
| SI | SHOULDER INNOVATIONS, INC. | $502.9M | — |
| KIDS | ORTHOPEDIATRICS CORP | $509.6M | — |
| NPCE | NeuroPace Inc | $521.6M | — |
| PSTV | PLUS THERAPEUTICS, INC. | $292.5M | — |
| SGHT | Sight Sciences, Inc. | $288.4M | — |
| OSUR | ORASURE TECHNOLOGIES INC | $276.8M |
| CERS | CERUS CORP | $585.1M | — |
